TP53 and Merkel cell skin cancer: Our results suggest that, although p53 activation plays a significant role in cell apoptosis during pyrvinium treatment, there are also p53-independent proapoptotic mechanisms that provide pyrvinium with an advantage as a novel therapy for treating TP53mut or TP53–/– MCC.